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Abstract. In this paper we present applications of the ACGT Master Ontology 
(MO) which is a new terminology resource for a transnational network 
providing data exchange in oncology, emphasizing the integration of both 
clinical and molecular data. The development of a new ontology was necessary 
due to problems with existing biomedical ontologies in oncology. The ACGT 
MO is a test case for the application of best practices in ontology development. 
This paper provides an overview of the application of the ontology within the 
ACGT project thus far.   
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1   Introduction 
Over the last decade the amount of data on cancers and their treatment has 
exploded due to advances in research methods and technologies. Recent research 
results have changed our understanding of fundamental aspects of cancer 
development at the molecular level. Nevertheless, irrespective of the fact that huge 
amounts of multilevel datasets (from the molecular to the organ and individual levels) 
are becoming available to biomedical researchers, the lack of a common infrastructure 
has prevented clinical research institutions from being able to mine and analyze 
disparate data sources efficiently and effectively. As a result, very few cross-site 
studies and multi-centric clinical trials are performed, and in most cases it is not 
possible to seamlessly integrate multi-level data. Moreover, clinical researchers and 
molecular biologists often find it hard to take advantage of each other’s expertise due 
to the absence of a cooperative environment which enables the sharing of data, 
resources, or tools for comparing results and experiments, and of a uniform platform 
supporting the seamless integration and analysis of disease-related data at all levels 
[1]. This situation severely jeopardizes research progress and hinders the translation 
of research results into benefits to patients.  
The Advancing Clinico-Genomic Trials on Cancer (ACGT) integrated project aims 
to address this obstacle by setting up a semantic grid infrastructure in support of 
multi-centric, post-genomic clinical trials [2]. This system is designed to enable the 
smooth and prompt transfer of laboratory findings to the clinical management and 
treatment of patients. Obviously, this goal can only be achieved if state-of-the-art 
semantic technologies are part of the IT environment. In order to meet this goal, the 
ACGT project needed an ontology to be utilized in the context of its selected Local-
As-View (LAV) data integration strategy [3]. In such a strategy the ontology plays the 
role of a global schema to which all local schemata are mapped, so that all their 
mapped equivalents are subsumed by the global schema. This requires that the global 
schema (i.e. the ontology) be sufficiently generic as to cover not only terminology, 
but also the meaning of all local schema constructs. The ACGT project achieves the 
semantic integration of heterogeneous biomedical databases through a service 
oriented, ontology driven mediator architecture that makes use of the ACGT-MO [4, 
5]. The new terminology resource which underlies this integration rests upon a 
thorough review and critical assessment of the state of the art in semantic 
representation of cancer research and management.  
2   Pre-Existing Ontologies and Terminologies 
Cancer has been a focus of interest in biomedical research for a very long time. As 
a result of this long history, a number of terminological resources exist that are of 
relevance to ACGT. In order to prevent redundancy, the project undertook a very 
detailed review. We will illustrate this selection process by focusing on two potential 
resources that did not meet our criteria of excellence, and hence were either not used 
in ACGT, or were used after considerable alteration. We will further mention two 
general biomedical resources selected for integration in the ACGT terminological 
network.   
When considering the development of an ontology-based information-sharing 
system for the cancer domain of the sort used by ACGT, the National Cancer Institute 
Thesaurus (NCIT) is a terminology resource of obvious relevance [6]. Yet, there are a 
number of drawbacks preventing the use of the NCIT as semantic resource of the 
ACGT project, in part because its formal resources are too meager for our purposes, 
with only a fraction of NCIT terms being supplied with formal definitions of the sort 
required by its official description logic (DL) framework. The NCIT contains only 
one relation, namely the subtype relation (is_a), as contrasted with the plurality of 
formally defined relations included, for example, within the OBO Relation Ontology 
[7]. Further, the NCIT is marred by a number of problems in its internal structure and 
coverage [8], including problems in the treatment of is_a. For a quick illustration of 
the inadequate treatment of is_a in the reviewed version of NCIT. let us consider the 
NCIT class Organism, which includes among its subtypes OtherOrganismGroupings; 
with this we have OtherOrganismGroupings is_a Organism [6]. Given the formal 
definition of the subtype relation this is clearly wrong; groupings of organisms are not 
themselves organisms.   
Another resource that has the aura of indispensability in a domain dealing with 
gene array data is the Microarray and Gene Expression Data (MGED) ontology [9]. 
Yet, even this highly used resource shows considerable deficiencies, including 
informal is_a relations. The inconsistency becomes obvious when the textual 
definitions – which are an asset to MGED – are taken into account: According to the 
MGED ontology Host is a subclass of EnvironmentalHistory. It is obvious that this 
cannot be a formal is_a relation. Taking a close look reveals an astonishing 
incoherence here: The definition of Host is: “Organisms or organism parts used as a 
designed part of the culture (e.g., red blood cells, stromal cells)” [9]. The definition of 
EnvironmentalHistory reads as follows: “A description of the conditions the organism 
has been exposed to that are not one of the variables under study” [9]. The thesis that 
an organism or organism part is a description clearly involves a crude category 
mistake (the confusion of use and mention). For some portions of the ACGT domain, 
however well-built and well maintained ontologies with high usability could be 
identified and reused within ACGT. This, as a matter of fact, applies both to the 
Foundational Model of Anatomy (FMA) [10] and the Gene Ontology (GO) [11], since 
they both fulfill the requirements on coherence and theoretical rigor specified in [12].   
Most of the current ontologies for life sciences start from terminology appearing in 
documentation systems as data and pertaining to the “subject matter” of the research 
carried out, such as concepts about the human body, diseases and microbiological 
processes. However, the data kept in the systems ACGT aims at supporting also 
pertain to the scientific processes of observation, measurement and experimentation 
together with all contextual factors. A model for integrating that data must include 
this aspect. The CIDOC CRM (ISO21127, [13]) is a core ontology originally 
developed for schema integration in the field of documenting the historical context 
and treatment of museum objects, including a generic model of scientific processes. 
Some concepts and relations of the latter were reused and refined for the ACGT MO. 
Effectively, developing a new ontology was imperative, since no single ontology 
or set of ontologies had the respective coverage and logical consistency.  
3   The ACGT Master Ontology 
3.1   Technical Details of the ACGT MO 
The intention of the ACGT MO [4] is to represent the domain of cancer research and 
management in a computationally tractable manner. As such, we regard it as a domain 
ontology. The initial version of the ACGT MO that was made public on the internet 
consists of 1300 classes. The ontology was built, and is being maintained, using the 
Protégé-OWL open-source ontology editor [14]. It is written in OWL-DL [15] and 
presented as an .owl file. The ACGT MO not only represents classes as linked via the 
basic taxonomical relation (is_a), but connects them via other semantic relations 
called “properties” in OWL terminology. The OBO Relation Ontology (RO) [7] has 
been used as a basis in this regard, as RO has been specifically developed to account 
for relations in biomedical ontologies [16]. Some properties of scientific observation 
were taken from the CIDOC CRM [13]. 
3.2   Methodology 
The ACGT MO has been developed in close collaboration with clinicians utilizing 
existing Clinical Report Forms (CRFs), which were used to gather documentation on 
the universals and classes in their respective target domains, and to understand the 
general semantics of form-based reporting of clinical observation.  All versions of the 
ontology have been reviewed by clinical partners who have proposed changes and 
extensions according to needs. In this process the problem of handling an ontology 
with more than 1300 classes for clinical users became apparent. Providing tools to 
examine the ontology in user-friendly ways emerged as inevitable. Yet, to ensure 
comprehensiveness of the representation of relevant portions of reality it was found 
necessary to go beyond the CRFs and the documentation provided by the clinical 
project partners. The latter governed the development of the leaf nodes of the ACGT 
MO, but we had to identify classes for a middle layer of the representation in order to 
ensure that the ontology provided the necessary reasoning support. Therefore, 
standard literature and standard classification systems were used, e.g. [17, 18, 19]. In 
order to provide a consistent and sound representation, the ACGT MO employs the 
resources of an Upper Ontology, which does not represent domain specific 
knowledge, but consists of classes that are generic and abstract [20]. The ACGT MO 
is based on Basic Formal Ontology (BFO) [21], which has proven to be highly 
applicable to the biomedical domain [22], and is now providing the advantage of 
common guidelines for ontology building to a multiplicity of research groups and 
organizations, 
It is a well-documented fact that well-built, coherent ontologies tend to be hard to 
understand for clinical users [23]. An is_a hierarchy based on BFO puts kinds of 
processes and kinds of objects on quite distant branches. The clinician should, 
nevertheless, have these associations readily available on the screen. We therefore 
proposed that the basis for these tools should be a viewing mechanism that should 
reflect the terms typically appearing together in particular clinical contexts, while the 
full ontology was running behind the scenes. The necessary associations may be 
found and activated by tracking the workflows commonly used in computer 
applications serving clinical practice. In the following we present several specific 
techniques and work styles that were employed in the development of the ACGT MO.   
Lassila et al. [24] categorized ontologies according to the amount of information 
they contain. Their classification ascribes the term “ontology” to nearly everything 
that is at least a finite controlled vocabulary with unambiguous interpretation of 
classes and term relationships and with strict hierarchical subclass relationships 
between classes. We disagree with this overly liberal terminological practice. 
Ontologies that meet more elaborate criteria, and contain a much richer internal 
structure were dubbed “heavyweight” and differentiated from so-called “lightweight” 
ontologies [25]. Among the criteria mentioned for “heavyweight ontologies” are, 
besides the subtype relation discussed above, also the presence of properties, value 
restrictions, general logical constraints, and disjoints. The ACGT MO has been 
designed, in this respect, to be to a heavyweight ontology. A basic principle of 
ontology development is that ontologies include only classes (types, universals) but 
not instances (tokens). Hence the ACGT MO does not include representations of real 
world instances but only of universals. One of the gold standards to be followed in 
order to ensure a proper structure of the taxonomy of universals, is the use of a formal 
subtype relation and the avoidance of the informal is_a relations mentioned above. 
The subtype relation (is_a) is formally defined as follows: A is_a B if and only if all 
instances of A are also instances  of B.  
In general, we embrace the thesis that a properly constructed ontology should steer 
clear of a taxonomical tree that allows multiple parent classes for the same child class 
(i.e. one child that inherits from multiple parents). The central aim is to avoid 
polysemy that often results from multiple inheritances. In the ACGT MO we 
completely avoided multiple inheritance.   
Another problematic case that can be found in a number of medical databases, 
terminologies and even “ontologies,” is the presence of so called Not Otherwise 
Specified (NOS) classes, e.g. “Brain Injury Not Otherwise Specified” or classes like 
“UnknownX” (“UnknownAffiliation”). Only recently havea number of revisions of 
SNOMED CT [26, 27] led to the deactivation of concepts involving the qualifier NOS 
such as 262686008 Brain injury NOS (disorder) and 162035000 Indigestion symptom 
NOS (finding). This demonstrates an increasing realist orientation in SNOMED CT. 
Already Cimino in his famous “Desiderata” essay [28] had counseled against the use 
of NOS and similar qualifiers. “Universals” of this kind do not, in fact, have any 
instances of their own; rather, they merely hint at a lack of data or knowledge. The 
alleged instances of those universals do not exhibit any shared properties, at least not 
necessarily. Therefore, we avoided such classes in the ACGT MO. The review of pre-
existing biomedical ontologies targeting the ACGT domain led to the decision to re-
use the FMA and the GO. Furthermore, some existing medical classifications and/or 
controlled vocabularies have been, or will be, slightly modified and added to the 
ontology. An example of this type is the TNM system [19].  
4   Database Integration Process 
The ACGT Semantic Mediation Layer (ACGT-SM) comprises a set of tools and 
resources that work together to serve processes of Database Integration and Semantic 
Mediation. The ACGT-MO is a core resource of this system, acting as Global Schema 
– i.e. a global framework for semantic homogenization – providing the formalization 
of the domain knowledge needed to support a variety of applications oriented towards 
clinical research and patient care. The ACGT-SM follows a Local-as-View Query 
Translation approach in order to cope with the problem of database integration. This 
means that data is not actually integrated, but is made accessible to users via a virtual 
repository. This repository represents the integration of the underlying databases, and 
the ACGT-MO acts here as database schema, providing resources for formulation of 
possible queries. The virtual repository has the shape of an RDF database, and the 
language selected for performing queries is SPARQL [29].  
   
Figure 1: ACGT Semantic Mediator Layer architecture 
 
The ACGT-SM comprises different tools addressing different problems, such as 
schema level heterogeneities and instance level conflicts both at the query and data 
levels. These tools are designed as independent web services that collaborate in the 
mediation process and are coordinated bythe Semantic Mediator. The system also 
includes a tool devoted to aid in the process of building mappings. This mapping tool 
uses the ACGT-MO, and is based on a graphical visualization of its structure. The 
users of this mapping tool navigate the ACGT-MO and an underlying database 
schema in order to mark the entities that are semantically equivalent. The architecture 
of this system is shown in Figure 1.  
The ACGT-SM exposes its data services using an OGSA-DAI [30] web based 
interface. The OGSA-DAI middleware allows easy access and integration of data via 
the grid. However, no grid infrastructure is needed to access these services. The 
ACGT-SM offers two main services, namely 1) to launch a query, and 2) to browse 
the schema. The latter shows a subset of the ACGT-SM underlying RDF schema. 
This subset is built taking into consideration the user profile.  
This software system has been tested with clinical relational and image databases 
[31], obtaining promising results. Currently the consortium is developing a final user 
query tool, with the aim of helping non technical users in the processes of building 
and launching queries.  
5   Exploitation of the ontology in a clinical trial management 
system 
The integration of existing data sources via the mediator is the general policy of the 
ACGT project. Yet the ultimate goal of ontology-based information management is to 
enable the direct integration of semantically consistent data created in different 
environments (e.g. clinical research, laboratory data, public health data). ACGT aims 
to provide solutions that demonstrate the possibility of creating data in an ontology-
governed way. To explore this approach, an Ontology-based Trial Management 
System (ObTiMA) is under development that enables those who undertake clinical 
trials to set up patient data management systems with comprehensive metadata by 
using the ACGT-MO [32]. This allows seamless integration of data collected in these 
systems into the ACGT mediator architecture. The main components of ObTiMA are 
the Trial Builder and the patient data management system. The Trial Builder allows a 
trial leader to define the master protocol, the Case Report Forms (CRFs) and the 
treatment plan for the trial in a way that is both semantically compliant with the 
ACGT MO and user-friendly. From these definitions, the patient data management 
system can be set up automatically. The data collected in the trial is stored in trial 
databases whose comprehensive metadata has been rendered from the start in terms of 
the ACGT-MO. The data can thus be seamlessly integrated through OGSA-DAI 
services [30] into the mediator architecture. Trial databases with comprehensive 
ontological metadata and the OGSA-DAI services are both automatically set up from 
the definitions made by the trial chairman in the Trial Builder 
In the following, we briefly describe how the Trial Builder allows the clinician to 
define all information needed to make integration possible. In setting up a trial, 
clinicians want to focus on the user interfaces and to adapt them to the specific 
workflow of the clinical trial planned. They do not wish to be concerned with 
theoretical aspects and design principles of databases or ontological metadata. 
Therefore, in ObTiMA, the trial leader defines both, by creating the CRFs for the 
intended trials. He is assisted by ObTiMA in defining the questions on the CRFs, the 
order in which the questions will be queried, and constraints on the answer 
possibilities. Creating a question on the CRF is supported by simply selecting 
appropriate terms from the ACGT MO. For example, assuming that the clinician 
wants to collect all information on a patient’s gender. He observes that a relation 
between the classes “Patient” and “Gender” exists in ACGT MO. In creating the 
corresponding question, he simply has to choose the class Gender. The attributes 
required in order to create the question on the CRF are then determined very easily. 
E.g. as answer possibilities for the question the values Male, Female, and 
AmbiguousGender are suggested, because the class Gender is defined as an 
enumeration in the ontology containing these values and a multiple choice question is 
subsequently automatically created on the CRF.   
 
 Figure 2: The ObTiMA ontology viewer. 
 
This procedure implements the semantics of the ontology in the CRFs in an 
automatic fashion.  
With the aim of setting up the appropriate database for storing the data, the 
following attributes are needed for each question: the question itself, the data type of 
the answer and optionally possible data values, range constraints and measurement 
units. These attributes will as far as possible be determined automatically from the 
path the trial leader has selected, but can later be changed according to need and 
experience of what works best. This process leads to the possibility of lessons learned 
in integration of the data collected in the clinical trial at hand to be incorporated into 
the semantics of the ontology. In this way, the ontology itself improves in reflection 
of advances made by the researchers using it. Through the integration of the ACGT-
MO into ObTiMA, data sharing between clinical trials becomes possible. This is 
necessary to leverage the collected data for further research for example in the 
creation of cross-trial meta-analyses.   
We are aware that this ambitious enterprise requires tools to overcome the gap 
between clinical practice and biomedical reality representation. Even if an ontology 
provides natural language definitions for its entities and relationships (in order to 
make them human understandable) they are still defined in a way that is not based on 
practical or clinical perceptions of reality. In order to meet this desideratum, the Trial 
Builder provides an application-specific view on the ontology, a view that is meant to 
assist clinicians engaged in clinical practice or clinical trial management.  
Recent studies showed that, under three different scenarios, the accuracy of 
SNOMED coding is only slightly over 50 % [33, 34]. One additional potential 
advantage of ObTiMA is that it may help put an end to some of the problems 
currently faced by those using coding techniques to map clinical data unto biomedical 
terminologies.  
Conclusions 
The ACGT project provides a novel terminological resource for cancer research 
and management. It has long been recognized that an obvious application for an 
ontology resource is to provide a stable common schema for a mediation system such 
as the one that serves integration across the ACGT network. ACGT has addressed 
also another problem which is to provide more efficient and reliable tools for coding 
of clinical data by providing an ontology-driven Clinical Trial Management system 
which aids the clinician in collecting the data in a way compliant with the ontology.  
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